Literature DB >> 13616731

Respiratory pathophysiology in chronic beryllium disease; review of thirty cases with some observations after long-term steroid therapy.

E A GAENSLER, J M VERSTRAETEN, W B WEIL, D W CUGELL, A MARKS, J B CADIGAN, R H JONES, M F ELLICOTT.   

Abstract

Entities:  

Keywords:  ACTH/therapeutic use; BERYLLIUM/poisoning; OCCUPATIONAL DISEASES; RESPIRATION

Mesh：

Substances：

Year:  1959        PMID： 13616731

Source DB:  PubMed          Journal:  AMA Arch Ind Health        ISSN： 0567-3933


× No keyword cloud information.
  6 in total

1.  An analysis of factors affecting the measurement of pulmonary diffusing capacity by the single breath method.

Authors:  J B CADIGAN; A MARKS; M F ELLICOTT; R H JONES; E A GAENSLER
Journal:  J Clin Invest       Date:  1961-08       Impact factor: 14.808

2.  The effect of paraquat on guanylate cyclase activity in relation to morphological changes of guinea pig lungs.

Authors:  S N Giri; G A Krishna
Journal:  Lung       Date:  1980       Impact factor: 2.584

3.  Pulmonary toxicity of beryllium in albino rat.

Authors:  K A Goel; V P Agrawal; V Garg
Journal:  Bull Environ Contam Toxicol       Date:  1980-01       Impact factor: 2.151

4.  Current treatment of chronic beryllium disease.

Authors:  Akshay Sood
Journal:  J Occup Environ Hyg       Date:  2009-12       Impact factor: 2.155

5.  Effect of inhaled corticosteroids on lung function in chronic beryllium disease.

Authors:  Margaret M Mroz; John H Ferguson; Anna V Faino; Annyce Mayer; Matthew Strand; Lisa A Maier
Journal:  Respir Med       Date:  2018-02-05       Impact factor: 3.415

6.  Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease.

Authors:  Margaret M Mroz; Lisa A Maier; Matthew Strand; Lori Silviera; Lee S Newman
Journal:  Am J Ind Med       Date:  2009-10       Impact factor: 2.214
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.